Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Adenis

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of CancerP Canal, C Gay, A Dezeuze, et al.
British Journal of Cancer|April 1, 2010
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard careN Penel, S Clisant, E Dansin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II studyC Borg, T André, G Mantion, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II study of cystemustine in advanced renal cancerJ Chauvergne, P Kerbrat, A Adenis, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2023
Scabies in French Guiana: Quantitative and qualitative factors associated with therapeutic failureR Blaizot, F Armanville, C Michaud, et al.
Epidemiology and Infection|January 17, 2017
High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological studyA Adenis, V Dufit, M Douine, et al.
Plos Neglected Tropical Diseases|September 22, 2025
Etiological spectrum and diagnostic features of lymphadenopathy in People Living with HIV in French Guiana: A 17-years multicenter retrospective case seriesMorgane Bourne-Watrin, Ugo Françoise, Sophie Alexandra Baron, et al.
Targeted Oncology|December 25, 2012
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implicationsA Italiano, E Saada, A Cioffi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)M Ducreux, A Adenis, J-P Pignon, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of CancerP Canal, C Gay, A Dezeuze, et al.
British Journal of Cancer|April 1, 2010
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard careN Penel, S Clisant, E Dansin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II studyC Borg, T André, G Mantion, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II study of cystemustine in advanced renal cancerJ Chauvergne, P Kerbrat, A Adenis, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2023
Scabies in French Guiana: Quantitative and qualitative factors associated with therapeutic failureR Blaizot, F Armanville, C Michaud, et al.
Epidemiology and Infection|January 17, 2017
High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological studyA Adenis, V Dufit, M Douine, et al.
Plos Neglected Tropical Diseases|September 22, 2025
Etiological spectrum and diagnostic features of lymphadenopathy in People Living with HIV in French Guiana: A 17-years multicenter retrospective case seriesMorgane Bourne-Watrin, Ugo Françoise, Sophie Alexandra Baron, et al.
Targeted Oncology|December 25, 2012
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implicationsA Italiano, E Saada, A Cioffi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)M Ducreux, A Adenis, J-P Pignon, et al.
Pageof 11